Completed
Arnuity® Ellipta® Drug Use Investigation
NCT03184480
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Nagasaki, Japan